CAS 125093-93-8

(lys1,pro2,5,arg3,4,tyr6)-vasoactivo*intestinal P

Descripción:

La sustancia química conocida como (lys1,pro2,5,arg3,4,tyr6)-péptido intestinal vasoactivo (VIP) es un neuropéptido que desempeña un papel crucial en varios procesos fisiológicos. Está compuesta por una secuencia de aminoácidos, incluyendo lisina, prolina, arginina y tirosina, que contribuyen a su actividad biológica. El VIP está principalmente involucrado en la regulación de la relajación del músculo liso, la vasodilatación y la estimulación de la secreción glandular, particularmente en el tracto gastrointestinal. También tiene efectos neuroprotectores y está implicado en la neurotransmisión dentro del sistema nervioso central. El péptido exhibe un alto grado de especificidad por sus receptores, que son parte de la familia de receptores acoplados a proteínas G. Su potencial terapéutico se está explorando en condiciones como el asma, la enfermedad inflamatoria intestinal y otros trastornos relacionados con los sistemas nervioso y digestivo. El número CAS 125093-93-8 identifica de manera única este compuesto, facilitando su reconocimiento en la literatura científica y bases de datos. En general, el VIP es una molécula significativa tanto en contextos fisiológicos como patológicos.

Fórmula: C₁₅₄H₂₅₇N₄₉O₄₀S

Sinónimos:

• VIP Antagonist
• H-Lys-Pro-Arg-Arg-Pro-Tyr-Thr-Asp-Asn-Tyr-Thr-Arg-Leu-Arg-Lys-Gln-Met-Ala-Val-Lys-Lys-Tyr-Leu-Asn-Ser-Ile-Leu-Asn-NH2

VIP Antagonist

CAS: 125093-93-8

VIP antagonist, a hybrid of neurotensin (6-11) and VIP (7-28), is a competitive antagonist of VIP-binding to glial cells. In rats with reduced masculine potential, The peptide markedly inhibits VIP-stimulated sexual behaviour. Furthermore, it has been shown to antagonize VIP receptors on non-small cell lung cancer cells, thereby inhibiting tumor growth in vitro and in vivo.

Fórmula: C₁₅₄H₂₅₇N₄₉O₄₀S

Pureza: 95.3%

Forma y color: White

Peso molecular: 3467.11

Ref: 01-4031352

VIP Antagonist

CAS: 125093-93-8

VIP Antagonist is a drug that inhibits the α7 nicotinic acetylcholine receptor and has been shown to have inhibitory properties against cancer tissues. The drug blocks the response element for VIP, inhibiting cyclase activity. This prevents the production of VIP and other neuropeptides, which are involved in nerve cell growth and survival. VIP Antagonist also inhibits toll-like receptor signaling pathways by blocking TLR2 and TLR4, which are receptors on immune cells that recognize bacterial products. In addition, this drug binds to human immunoglobulin G (IgG) and prevents it from binding to its Fc receptor on immune cells, thus preventing IgG-mediated complement activation or antibody-dependent cellular cytotoxicity.

Fórmula: C₁₅₄H₂₅₇N₄₉O₄₀S

Pureza: Min. 95%

Peso molecular: 3,467.06 g/mol

Ref: 3D-PVA-3757-PI

VIP Antagonist

CAS: 125093-93-8

Custom research peptide; min purity 95%. For different specs please use the Peptide Quote Tool

Fórmula: C₁₅₄H₂₅₇N₄₉O₄₀S

Peso molecular: 3,467.13 g/mol

Ref: 3D-PP50098

VIP Antagonist

CAS: 125093-93-8

The VIP antagonist is a model system that has been shown to inhibit the activity of VIP in fetal bovine lung. The VIP antagonist has been shown to be effective against a variety of cancers, including colon cancer and prostate cancer. It also inhibits the production of cytosolic Ca2+ in human skin cells and has anti-inflammatory properties. The VIP antagonist's biological properties have been studied extensively, including its ability to induce neuronal death by inhibiting the release of neurotransmitters from neurons in culture.

Fórmula: C₁₅₄H₂₅₇N₄₉O₄₀S

Pureza: Min. 95%

Peso molecular: 3,467.06 g/mol

Ref: 3D-FV110467